Overview of Recent Trends in the Management of Metastatic Anal Cancer
Open Access
- 1 January 2015
- journal article
- Published by Elmer Press, Inc. in World Journal of Oncology
- Vol. 6 (1), 311-315
- https://doi.org/10.14740/wjon866w
Abstract
Anal cancer is a relatively rare gastrointestinal tumor with roughly 7,000 new cases per year. Metastatic anal cancer as an initial presentation occurs in 10-20% of the patients. Treatment for localized disease is well established with concurrent chemoradiation (CCR) therapy as the standard of care; however, metastatic anal cancer remains a therapeutic challenge. National Comprehensive Cancer Network (NCCN) guidelines recommend systemic chemotherapy as the initial choice of treatment for metastatic anal disease. NCCN also recognizes the fact that there are limited data to influence the management of metastatic anal cancer but that some evidence suggests flouropyrimidine and cisplatin as the initial choice of treatment outside the setting of clinical trial. If the patient fails this regimen, options become limited with no strong level I evidence available to guide the treatment. We present two cases of metastatic anal cancer and discuss the potential treatment strategies after failing the initial systemic chemotherapy.World J Oncol. 2015;6(1):311-315doi: http://dx.doi.org/10.14740/wjon866wKeywords
This publication has 36 references indexed in Scilit:
- Management of Two Cases of Recurrent Anal CarcinomaCase Reports in Oncology, 2013
- The Role of EGFR Inhibitors in the Treatment of Metastatic Anal Canal Carcinoma: A Case SeriesJournal of Oncology, 2011
- Cetuximab-Based Treatment of Metastatic Anal Cancer: Correlation of Response with KRAS Mutational StatusOncology, 2009
- Abdominoperineal Resection for Anal CancerDiseases of the Colon & Rectum, 2008
- Evidence of Clinical Activity for Cetuximab Combined with Irinotecan in a Patient with Refractory Anal Canal Squamous-Cell Carcinoma: Report of a CaseDiseases of the Colon & Rectum, 2007
- Combining Cisplatin and Mitomycin with Radiotherapy in Anal CarcinomaDiseases of the Colon & Rectum, 2007
- Metastatic Anal Cancer: The Search for CureOncology Research and Treatment, 2006
- Epidermal Growth Factor Receptor Expression in Anal Canal CarcinomaAmerican Journal of Clinical Pathology, 2005
- Cisplatin-based combined modality therapy for anal carcinomaCancer, 2003
- Respective roles of radiotherapy and surgery in the management of epidermoid carcinoma of the anal marginDiseases of the Colon & Rectum, 1992